The Maryland District Court’s decision in the American Academy of Pediatrics case and ongoing concerns about youth vaping have raised significant questions regarding the outlook for FDA regulation of these and other tobacco products in 2020. Meanwhile, the 2018 Farm Bill opened the floodgates of a sprawling market for hemp-derived products, challenging FDA’s ability to exert its enforcement authority over this new and burgeoning industry.
During this installment of Latham & Watkins’ We’ve Got Washington Covered webcast series, partners Ben Haas and Elizabeth Richards examine issues associated with FDA's recent “ban” on flavored e-cigarette products and what to expect in 2020 regarding FDA regulation of vaping. In addition, they will discuss new developments in connection with FDA’s oversight over certain cannabis-derived substances and how these substances may be regulated moving forward. The featured topics will include:
Ben Haas, Partner
Elizabeth Richards, Partner
Latham & Watkins certifies that this activity has been approved for MCLE credit by (i) the State Bar of California in the amount of 1.00 hour of general credit, (ii) the State Bar of New York in the amount of 1.00 hour of areas of professional practice credit, and (iii) the State Bar of Texas Committee on MCLE in the amount of 1.00 hour of general credit.
If you haven't previously registered for this webcast, please register here and a confirmation email will be sent to you. An on-demand version of this webcast will be availalble a few days after the live broadcast – an email with the recording link will be sent to all registrants.